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Abstract
Prenatal glucocorticoid overexposure has been shown to programme adult cardiovascular
function in a range of species, but much less is known about the long-term effects of neonatal
glucocorticoid overexposure. In horses, prenatal maturation of the hypothalamus–pituitary–
adrenal axis and the normal prepartum surge in fetal cortisol occur late in gestation compared
to other precocious species. Cortisol levels continue to rise in the hours after birth of full-term
foals and increase further in the subsequent days in premature, dysmature and maladapted
foals. Thus, this study examined the adult cardiovascular consequences of neonatal cortisol
overexposure induced by adrenocorticotropic hormone administration to full-term male
and female pony foals. After catheterisation at 2–3 years of age, basal arterial blood pressures
(BP) and heart rate were measured together with the responses to phenylephrine (PE) and
sodium nitroprusside (SNP). These data were used to assess cardiac baroreflex sensitivity.
Neonatal cortisol overexposure reduced both the pressor and bradycardic responses to PE
in the young adult males, but not females. It also enhanced the initial hypotensive response
to SNP, slowed recovery of BP after infusion and reduced the gain of the cardiac baroreflex
in the females, but not males. Basal diastolic pressure and cardiac baroreflex sensitivity also
differed with sex, irrespective of neonatal treatment. The results show that there is a window
of susceptibility for glucocorticoid programming during the immediate neonatal period that
alters cardiovascular function in young adult horses in a sex-linked manner.
Introduction
Human epidemiological observations and studies in experimental animals have demonstrated
that environmental conditions during pregnancy that alter birth weight can have consequences
for offspring phenotype long after birth.1–4 More specifically, changes in maternal nutrition and
levels of stress during pregnancy lead to cardiovascular, metabolic and endocrine dysfunction in
the adult offspring in a range of laboratory and farm species including rodents, primates, pigs
and sheep.5 In horses, maternal undernutrition and dietary manipulations in late pregnancy are
known to alter endocrine and metabolic function in newborn and juvenile foals in association
with reduced birthweight.6–8 Similarly, manipulating intrauterine growth by embryo transfer
between horse breeds of different sizes leads to specific changes in baroreceptor sensitivity, glu-
cose metabolism, insulin sensitivity and adrenal function in newborn foals or yearlings, both
when birth weight is restricted or enhanced with respect to their genetic norms.9–12 Even when
there is little if any change in birth weight, adult cardiometabolic phenotype can be programmed
by environmental cues acting during intrauterine development.5
Many of the environmental conditions known to programme phenotype in utero raise cir-
culating glucocorticoid levels in the mother and/or fetus.13,14 Indeed, this glucocorticoid over-
exposure may contribute to the developmental programming, as glucocorticoids are known to
regulate fetal growth and development both directly and indirectly by changes in placental
function.14,15 In addition, exposure of the offspring to synthetic glucocorticoids in utero by
maternal administration during pregnancy has been shown to induce postnatal cardiometabolic
and endocrine dysfunction in the offspring of several species.16–19 In pregnant mares for
instance, maternal administration of dexamethasone in late pregnancy is known to alter pan-
creatic β-cell function in their 12-week-old foals in the absence of any change in birth weight.20
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Furthermore, in rats, neonatal administration of the synthetic
glucocorticoid, dexamethasone, programmes cardiac dysfunction
in the adult offspring.21,22 However, much less is known about
the long-term cardiovascular implications of overexposure to
the natural glucocorticoids, particularly in the immediate neonatal
period.17,23
In horses, maturation of the fetal hypothalamic–pituitary–
adrenal (HPA) axis occurs relatively late in gestation with plasma
cortisol levels continuing to rise in the normal full-term foal in the
hours after birth in contrast in findings in other precocious
species.24 Cortisol levels rise still further in the days after birth
in foals that are premature or dysmature at birth or that develop
maladaptation syndrome after birth.25,26 Consequently, the period
of programming by endogenous glucocorticoid is likely to extend
into the neonatal period in the horse, as seen in more altricial spe-
cies like the rat.10 Indeed, recent studies have shown the elevating
cortisol levels experimentally in normal foals in the first few days
after birth affects functioning of the HPA axis and pancreatic β
cells 2–12 weeks later and HPA axis function and muscle insulin
receptor abundance in the young adult horse.27–30 However, little is
known about the effects of neonatal overexposure to glucocorti-
coids on equine cardiovascular function later in life, although ter-
minal differentiation of several tissues, like the lung and kidney, is
known to continue after birth in the foal, unlike many other preco-
cious species.31 Indeed, blood pressure (BP) and baroreceptor
sensitivity continue to alter developmentally during the first few
weeks of life in healthy-term foals.32–34 This study therefore exam-
ined the effect of raising endogenous cortisol concentrations in
newborn pony foals by adrenocorticotropic hormone (ACTH)
administration on their cardiovascular function and baroreceptor
sensitivity 2–3 years later relative to controls that received saline. It
also investigated the extent to which the long-term cardiovascular
effects of neonatal cortisol overexposure were sex-linked, as meta-
bolic function has been shown to be sexually dimorphic in both
newborn and older ponies.28,34 The study tested the hypothesis that
cardiovascular responsiveness and baroreceptor sensitivity in
young adult ponies are altered by neonatal cortisol overexposure.
Materials and methods
Animals
Seventeen ponies (nine female and eight males) were born sponta-
neously at full term (approximately 330 d in pony mares) and
weaned at 5–6 months. Thereafter, until catheterisation, they were
kept in single sex groups at grazing during the day and in covered
yards at night with ad libitum access to hay and water. Body con-
dition score was maintained at moderate from weaning to the end
of the protocol. All animals received equine tetanus antitoxin
shortly after birth and regular worming and hoof trimming.
After catheterisation as adults, the animals were housed individu-
ally in stables within sight and sound of other horses and with ad
libitum hay and water.
Experimental procedures
All procedures were carried out under the Animal (Scientific
Procedures) Act 1986 of the UK Government and were approved
by the Animal Welfare and Ethical Review Body of the University
of Cambridge
Foals
After birth, foals received intramuscular injections of either saline
as a control procedure (0.9% NaCl im; n = 8, four males and four
females) or long-acting ACTH1–24 (0.125 mg im; n = 9, four males
and five females, Depot Synacthen; Alliance Pharmaceuticals Ltd,
Wiltshire, UK) to raise plasma cortisol levels to values similar to
those seen in premature, dysmature or ill foals.26,35,36 The injections
were given twice daily at 09.00 h and 17.00 h for the first 5 d after
birth. Blood samples were taken daily from the jugular vein during
this period to measure plasma cortisol concentrations using an
immunoassay validated for equine plasma as described previ-
ously.27 Over the 5 d of treatment, plasma cortisol concentrations
were significantly higher in ACTH treated (183.7 ± 22.5 ng/ml,
n = 9) than control foals (20.3 ± 2.4 ng/ml, n = 8, P < 0.01)
and were unaffected by sex of the foals in either group
(P > 0.05, two-way analysis of variance (ANOVA)). Foals were
assigned to either the saline or ACTH group in the order in which
they were born on the basis of their sex to ensure an even sex dis-
tribution between treatments. Foal birth weight did not differ with
sex or between the treatment groups to which they were assigned
(Table 1, P > 0.05, two-way ANOVA).
Adults
Surgical procedures. Between 23 and 34 months of age, the ponies
were catheterised under strict aseptic conditions after an overnight
fast. Anaesthesia was induced using ketamine (2.2 mg/kg, Ketaset;
Ford Dodge Animal Health Ltd, Southampton, UK) and diazepam
(0.01 mg/kg Diazepam; Hameln Pharmaceuticals Ltd, Gloucester,
UK) given via the jugular vein. After intubation, anaesthesia was
maintained with 1.5–2.0% isoflurane in O2, using intermittent pos-
itive pressure ventilation. The horses were placed in left lateral
recumbency on an inflatable operating table. Polyvinyl catheters
(outer diameter 1.52 mm; inner diameter 0.86 mm; Critchley,
Electrical Products Ltd, Silverwater, New South Wales, Australia)
were inserted into the circumflex artery and vein, with their tips
advanced into the dorsal aorta and vena cava, respectively. The
catheters were filled with heparinised saline (100 IU heparin/ml
in 0.9% w/v NaCl) and sealed with sterile brass pins. They were
exteriorised via a keyhole incision in the flank and housed in a
bag sutured to the skin. Antibiotics (1 ml/25 kg, procaine penicillin
BP 200 mg and dihydrostreptomycin sulphate BP (vet) 250 mg;
Pen & Strep; Norbrook Laboratories Ltd, UK) and an anti-
inflammatory (1.1 mg/kg, flunixin meglumine; Finadyne 50 mg;
Shering – Plough Ltd, Wewyn Garden City, Herts, AL7 1TW,
UK) were given intramuscularly at the end of the surgery.
Catheters were flushed daily with heparinised saline (100 IU
heparin/ml in 0.9% w/v NaCl) before cardiovascular studies were
started after at least 5 d of post-operative recovery. All animals had
been catheterised previously as yearlings for other metabolic and
endocrine studies.28,30
Cardiovascular studies. Measurements of arterial BP were made
via a pressure transducer (COBE; Argon Division, Maxxim
Medical, Athens, TX, USA) set at the level of the heart using a
custom-built data acquisition system (Maastricht-Programmable
AcQuistion – IDEEQ 2.05, Maastricht Instruments, Maastricht,
The Netherlands). Diastolic, systolic and mean arterial BPs
(mmHg) together with heart rate (HR, beats per minutes) were
obtained from the pressure recordings.37,38 After 10 min of con-
tinuous recording of basal BPs and HR, either phenylephrine
(PE, 6 μg/kg/min; Sigma-Aldrich Co. Ltd, Haverhill, UK) or
sodium nitroprusside (SNP, 2.5 μg/kg/min; Sigma-Aldrich Co.
Ltd, Haverhill, UK) was infused intravenously for 10 min to induce
episodes of acute hypertension or acute hypotension, respectively.
Recording was continued throughout the infusion period and
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for 10 min after cessation of infusion. The two infusions were car-
ried out on consecutive days in a random order. The mean age of
the ponies at the time of the cardiovascular study was 30.9 ± 0.8
months and did not differ with sex or neonatal treatment
(n = 17, P > 0.05, two-way ANOVA). Body weight at the time
of the cardiovascular studies also did not differ with sex or neonatal
treatment (Table 1).
All animals were familiar with the environment used for the
experimental studies as they had undergone additional metabolic
and endocrine assessments in the preceding month. At the time of
the cardiovascular measurements, none of the females showed any
of the standard behavioural signs of estrus, such as tail deviation,
rhythmic eversion of the clitoris, frequent urination, pelvic lower-
ing or straddling of the hind limbs in the vicinity of a male.39 At the
end of the cardiovascular protocol, the animals were either
rehomed (n = 9) after discharge from the Animals (Scientific
Procedures) Act 1986 or euthanised (n= 8) by intravenous admin-
istration of a lethal dose of anaesthetic (Pentobaribitone sodium,
200 mg/kg, Pentoject; Animal Care Ltd, Dunnington, York, UK)
for the collection of tissues for teaching and other research studies.
Data analyses
For each animal, the average for mean arterial BP (mean BP) and
HR were calculated every 10 s from the 500-Hz recordings during
the 10-min baseline, infusion and recovery periods. Cardiac
baroreflex curves were then constructed by plotting values for
mean BP against HR during basal conditions and during changes
induced by infusion of PE and SNP. The correlation data were
fitted by a logistic sigmoidal curve and the maximum slope of
the relationship, representing the gain of the cardiac baroreflex
was calculated as ((HRmax − HRmin) × Gain coefficient)/4), as
described previously.40 Mean cardiac baroreflex curves were then
constructed for each treatment group with SEM values for both
mean BP and HR. Curves through the mean data points were
drawn using a Fit spine/LOWESS (locally weighted scatterplot
smoothing) function.38
To further evaluate the pressor and cardiac chronotropic
responses to each agonist, mean BP and HR responses to PE or
SNPwere also constructed by plotting themaximal change in value
from the mean baseline for each minute of infusion for each ani-
mal. Changes from baseline in continuous cardiovascular data
were then summarised over 5-min epochs and used to calculate
the areas either under the curve (AUC) or above the curve
(AAC) for the changes in mean BP and HR from baseline. Data
from these 5-min epochs were then averaged for all the animals
in each treatment group to providemean pressor and cardiac chro-
notropic responses to the agonists and are presented with their
respective SEM.38
Statistical analyses
All data are expressed as mean ± SEM and analysed statistically by
two-way ANOVA using neonatal treatment and time or neonatal
treatment and sex of the ponies as factors with the Holm–
Sidak post hoc test. Statistical analyses were performed using
Table 1. Mean ± SEM body weight at birth and at the time of together with basal values of arterial diastolic, systolic and mean arterial BP (mmHg) and HR (beats per
min, bpm) before infusion of PE and SNP and themaximum andminimum values of these variables during the 10min of infusion in all ponies at 2–3 years of age and in
the males and females separately after neonatal treatment with either saline or ACTH. Doses of drugs are given in the text
Number of ponies
Saline ACTH
All Male Female All Male Female
8 4 4 9 4 5
Body weight
At birth (kg) 28.6 ± 2.6 31.2 ± 4.6 26.1 ± 2.6 28.5 ± 2.3 29.2 ± 4.8 27.9 ± 2.1
At study (kg) 230 ± 16 238 ± 14 223 ± 32 246 ± 14 248 ± 28 244 ± 17
Basal values
Diastolic BP (mmHg)* 89.3 ± 4.3 99.6 ± 3.7 79.1 ± 1.3 92.7 ± 4.3 100.8 ± 5.7 86.3 ± 4.7
Systolic BP (mmHg) 135.2 ± 8.3 143.6 ± 5.6 126.8 ± 15.6 139.7 ± 9.3 154.5 ± 14.1 127.9 ± 10.6
Mean BP (mmHg) 104.6 ± 4.8 114.3 ± 3.6 95.0 ± 5.6 108.4 ± 5.8 118.7 ± 8.3 100.2 ± 6.4
HR (bpm) 46.3 ± 2.1 48.0 ± 3.5 44.7 ± 2.4 45.9 ± 1.8 42.6 ± 1.8 48.7 ± 2.3
PE infusion
Maximum diastolic BP (mmHg) 167.6 ± 9.7 177.8 ± 11.3 157.3 ± 15.6 159.0 ± 7.0 168.8 ± 12.2 151.2 ± 7.1
Maximum systolic BP (mmHg) 211.9 ± 13.9 217.2 ± 6.0 206.5 ± 29.0 217.7 ± 15.9 236.2 ± 25.8 203.0 ± 19.6
Maximum mean BP (mmHg) 180.6 ± 10.6 189.7 ± 9.5 171.5 ± 19.4 177.4 ± 9.6 190.3 ± 16.0 167.1 ± 10.8
Minimum HR (bpm) 28.0 ± 1.4 27.6 ± 1.7 28.4 ± 2.5 28.2 ± 1.5 28.4 ± 2.5 28.9 ± 2.5
SNP infusion
Minimum diastolic BP (mmHg)* 61.7 ± 4.9 71.6 ± 4.5 52.0 ± 5.0 69.1 ± 4.9 82.5 ± 2.5 58.4 ± 4.4
Minimum systolic BP (mmHg)* 97.4 ± 6.7 108.4 ± 8.7 86.4 ± 7.2 104.8 ± 8.5 120.9 ± 9.4 91.9 ± 10.5
Minimum mean BP (mmHg)* 73.3 ± 5.5 85.0 ± 5.9 61.6 ± 4.2 81.4 ± 5.8 94.9 ± 4.5 70.5 ± 6.6
Maximum HR (bpm) 79.1 ± 4.9 74.3 ± 5.9 83.9 ± 7.9 76.2 ± 3.8 76.7 ± 8.5 75.7 ± 3.1
*Sex effect by two-way ANOVA P < 0.01.
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Sigma-Stat (Statistical Software version 2.0, San Jose, CA, USA).
For all statistical tests, significance was accepted when P ≤ 0.05.
Results
Basal cardiovascular measurements
During the basal recording period before infusion of PE or SNP,
there were no significant differences in the average systolic, dia-
stolic or mean arterial BP between the ACTH- and saline-treated
groups of ponies (Table 1). However, diastolic pressure differed
with sex of the ponies and was higher in males relative to females,
irrespective of their neonatal treatment (Table 1, two-way
ANOVA, n = 17, P < 0.01). Neither systolic nor mean BP differed
with sex of the ponies during the basal recording period (Table 1).
There were also no significant differences in basal HR with either
sex or neonatal treatment (Table 1). These basal HR and BP mea-
surements were within the range of values published previously for
adult ponies and other small equine breeds using non-invasive
methods or short-term percutaneous catheterisation.41–45
Hypertensive challenge: cardiovascular responses to PE
There were rapid increases in mean BP and reductions in HR dur-
ing the first 5 min of PE infusion in all the ponies, irrespective of
their neonatal treatment. These data are presented for all animals
in each treatment group irrespective of sex (Fig. 1a – i and ii) and
for the males and females separately (Fig. 1b and c, respectively).
The maximum values of the absolute and increment in mean BP
during PE infusion were not affected by sex of the animals or their
neonatal treatment (Table 1). These values for diastolic and systolic
BP as well as the lowest HR and the maximum decrement in HR
during infusion were also unrelated to sex or neonatal treatment
(data not shown, two-way ANOVA, P > 0.05, all cases).
When the sexes were combined within each treatment group,
neonatal treatment had a significant effect on the AUC for the
change in mean BP during and after the PE infusion (Fig. 1a – iii).
Post hoc analyses showed that the AUC for mean BP was signifi-
cantly reduced in the ACTH relative to the saline-treated ponies for
the first and second 5-min epochs of infusion (Fig. 1a – iii).
However, analysis of the data by sex showed that the depressive
effect of neonatal treatment on the AUC for the change in mean
BP during infusion was due primarily to the males (Fig. 1b – iii)
and not the females (Fig. 1c – iii). There were no effects of neonatal
treatment on the AAC for the change inHR for either 5-min period
during infusion, when the sexes were combined (Fig. 1a – iv).
However, in the males only, neonatal treatment reduced the
AAC for the decrement in HR during the 5-min epochs during
PE infusion (Fig. 1b – iv and c – iv). Neonatal treatment also
had no significant effect on the AAC for the change in HR during
the recovery period either when the sexes were combined or
analysed separately (Fig. 1).
Hypotensive challenge: cardiovascular responses to SNP
During SNP infusion, there were gradual falls in mean BP and
increases in HR during the first 5 min of infusion in all the animals
studied (Fig. 2).When the data from the ACTH- and saline-treated
groups were analysed with the sexes combined within each group,
neonatal treatment had no effect on the fall in mean BP or on the
rise in HR during infusion (Fig. 2a – i and ii). The minimummean
BP and the maximum change in mean BP from baseline during the
10-min infusion period were also unaffected by neonatal treatment
(Table 1). Similar findings were observed for the minimum dia-
stolic and systolic BPs and their mean decrements during infusion
(data not shown, two-way ANOVA, P > 0.05, all cases). With the
sexes combined, neonatal treatment affected the AAC for the
change in mean BP in response to SNP, which post hoc analyses
showed was due primarily to a slower recovery of mean BP
post-infusion, with a greater AAC in ACTH than saline-treated
ponies during both 5-min periods after ending the infusion
(Fig. 2a – i and iii). There were no differences in the HR responses,
nor in AUC for the change in HR, with treatment when the sexes
within each group were combined (Table 1; Fig. 2a – ii and iv).
Analysis of data by sex showed that males and females differed
in their BP responses to SNP infusion, particularly after neonatal
ACTH treatment (Fig. 2b and c). Minimum diastolic, systolic and
mean BPs in response to SNP infusion were lower in females than
males irrespective of treatment, in line with the lower basal dia-
stolic BP (Table 1). For the first 5 min of infusion, the AAC for
mean BP was significantly greater in ACTH than saline-treated
females but not males (Fig. 2b – iii and c – iii). The slow recovery
of mean BP after ending the infusion in the ACTH-treated animals
was also more pronounced in females than males, with a signifi-
cantly greater AAC for mean BP for the two 5-min periods after
ending infusion in the female but not the male ACTH-treated
ponies relative to their saline-treated counterparts (Fig. 2b – iii
and c – iii). No significant differences in the HR responses were
observed between the sexes either during or after ending SNP infu-
sion (Table 2; Fig. 2b – ii and iv, and c – ii and iv).
Cardiac baroreflex curves
The changes in HR in response to alterations in mean BP induced
by both infusions were used to generate cardiac baroreflex function
curves (Fig. 3). There were no differences in theminimum ormaxi-
mumHR, or in the baroreflex gain, between the saline- andACTH-
treated ponies when the two sexes in each treatment group were
combined (Table 2; Fig. 3). However, there were interactions
between neonatal treatment and the sex of the ponies in determining
the gain of the baroreflex curve with differences between males and
females in the control group and with neonatal treatment in female
but not male ponies (Table 2). The overall gain of the autonomic
baroreflex function was markedly blunted in male relative to
female ponies in the control, saline-treated groups (Table 2).
Conversely, neonatal ACTH treatment reduced the gain of the auto-
nomic baroreflex function only in female but not male ponies
(Table 2).
Differential analysis of the changes in HR in response to acute
hypotension and acute hypertension can be used to give further
insight to the partial effects on the sympathetic and parasympa-
thetic components of the baroreflex function curve.32,37 This analy-
sis suggested that sympathetic dominance was affected by both
neonatal treatment and the sex of the ponies (Fig. 4a). Within
the saline-treated ponies, the sympathetic component of the bar-
oreflex function curve seemed more dominant in females than
males with a faster increment in HR in response to acute hypoten-
sion in the females (Fig. 4a – ii and iii). Neonatal ACTH treatment
had no apparent effect on the sympathetic component of the bar-
oreflex function curve in the males (Fig. 4a – ii) but attenuated the
HR response to acute hypotension in the females (Fig. 4a – iii).
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Neither neonatal treatment nor sex of the ponies appeared to affect
the parasympathetic component of the autonomic baroreflex
function (Fig. 4b).
Discussion
The data show that neonatal overexposure to cortisol induced by
ACTH treatment in the days immediately after birth programmes
long-term changes in cardiovascular function and cardiac barore-
ceptor sensitivity in a sex-linked manner in young adult horses.
More specifically, neonatal cortisol overexposure reduced the
pressor response to PE in the male but not female ponies.
Conversely, in females but not males, neonatal cortisol exposure
enhanced the early hypotensive response to SNP and slowed recov-
ery of mean BP to normal values after the end of infusion without
affecting the HR response. This means that for a greater SNP-
induced fall in mean BP in the ACTH-treated females, there
was a similar HR increment to that seen in the saline-treated con-
trols. Further analysis of these data suggested a blunted sympa-
thetic component to the cardiac autonomic baroreflex function
in the females after neonatal cortisol overexposure that was not
seen in the ACTH-treated males. However, relative to the females,
males had a depressed gain in autonomic baroreflex function in the
control group and a higher basal diastolic pressure, irrespective of
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Fig. 1. Mean (±SEM) values of the change (Δ) in mean
arterial BP (mmHg, i) and HR (beats per minute, bpm, ii)
from baseline with respect to time from the start of infu-
sion and the AUC (units =mmHg/5 min × 10−2) for mean
arterial BP (iii) and AAC (units = bpm/5 min × 10−2) for
HR (iv) over 5-min periods in response to intravenous
infusion of PE for 10 min (bar, 6 μg/kg/min) in ponies
at 2–3 years of age after neonatal treatment with either
saline (open symbols and bars, n = 8) or ACTH (filled
symbols and bars, n = 9) for (a) all animals irrespective
of sex, (b) males only (saline, n = 4; ACTH, n = 4) and (c)
females only (saline, n = 4; ACTH, n = 5). Significant
treatment effect (two-way ANOVA shown with a bar with
the Holm–Sidak post hoc test shown with *, P < 0.05, for
specific time periods).
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neonatal treatment. Collectively, these findings show that neonatal
cortisol overexposure, like that seen in premature and dysmature
foals, has long-term consequences for cardiovascular function in
the horse in support of the study hypothesis. However, the basal
cardiovascular profile and the specific changes in adult cardio-
vascular function programmed by neonatal ACTH treatment
depend on the sex of the pony.
Previous studies in a range of species have shown that prenatal
overexposure to either synthetic or natural glucocorticoids affects
development of the heart and blood vessels and leads to postnatal
cardiovascular dysfunction with hypertension and altered barore-
ceptor function in adulthood.17–19,46–49 The current study in ponies
shows that long-term cardiovascular function and its regulation
are also affected in early adulthood by overexposure to the natural
glucocorticoid, cortisol, in the immediate neonatal period. The
smaller hypertensive response to α1-adrenergic receptor agonist,
PE, and the slower recovery of BP after cessation of infusion of
the nitric oxide (NO) donor, SNP, despite normal HR responses,
indicate that the regulation of peripheral vascular tone may be
impaired in young adult horses after neonatal cortisol overexpo-
sure. Specifically, the data suggest impaired α1-adrenergic constric-
tor and/or enhanced NO-dependent dilator function in the
peripheral vasculature of horses treated with ACTH during the
neonatal period. In premature human infants treated neonatally
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Fig. 2. Mean (± SEM) values of the change in arterial BP
(mmHg, i) and HR (beats per minute, bpm, ii) from base-
line with respect to time from the start of infusion and
the AAC (units = mmHg/5 min × 10−2) for mean arterial
BP (iii) and AUC (units = bpm/min/5 min × 10−2) for HR
(iv) over 5-min periods in response to intravenous infu-
sion of SNP for 10 min (bar, 2.5 μg/kg/min) in ponies
at 2–3 years of age after neonatal treatment with either
saline (open symbols and bars, n= 8) or ACTH (filled sym-
bols and bars, n= 9) for (a) all animals irrespective of sex,
(b) males only (saline, n = 4; ACTH, n = 4) and (c) females
only (saline, n = 4; ACTH, n = 5). Significant treatment
effect (two-way ANOVA by shown with a bar with the
Holm–Sidak post hoc test shown with a *, P < 0.05 for
specific times periods). †Significantly different from
value in the males at the same time period (two-way
ANOVA, P < 0.02 with the Holm–Sidak post hoc test).
6 O. A. Valenzuela et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2040174420000446
Downloaded from https://www.cambridge.org/core. IP address: 82.5.208.225, on 23 Jun 2020 at 10:46:48, subject to the Cambridge Core terms of use, available at
with dexamethasone, cardiovascular responses to psychological
stress were blunted at school age with smaller increases in plasma
norepinephrine.50 Furthermore, in sheep, maternal antenatal treat-
ment with dexamethasone attenuated vascular vasoconstrictor
responses to noradrenaline in the newborn but not adult
offspring.51–53 This treatment also enhanced the vasodilator
response of femoral vessels to SNP and the vasoconstrictor
response to blockade of NO production in the newborn lamb.51,53
Similarly, antenatal treatment of pregnant sheep with the synthetic
glucocorticoid, betamethasone, programmed an enhanced dilator
response to the endothelium-dependent agonist, acetylcholine in
small resistance arteries of their 1- to 2-year-old offspring.54
Consequently, altered vascular NO production and/or NO sensi-
tivity may also contribute to the impaired pressor responses to
PE and the prolonged depressor effect of SNP observed in the cur-
rent study of adult horses overexposed to cortisol neonatally.
The cortisol-induced changes in the BP responses in the present
study may also reflect programmed cardiac dysfunction affecting
stroke volume and cardiac output. Neonatal treatment of term rat
pups with dexamethasone led to thinning of the left ventricular
wall and to decreased proliferation and accelerated terminal differ-
entiation of the cardiomyocytes by weaning in association with
modifications in cardiac DNA methylation.55–57 In adulthood, this
neonatal treatment led to a reduced heart weight, hypertrophic
cardiomyopathy, hypertension and a shorter life span.21,22,58–60
Functionally, the hearts of adult rats treated with dexamethasone
during the neonatal period had an elevated left ventricular end dia-
stolic pressure, a smaller ejection fraction and did not adapt to
imposed changes in pre- and after-load, indicative of a failed
Frank–Starling mechanism.21,22 These impaired cardiac responses
were accompanied by lower circulating levels of NO metabolites
and reduced cardiac abundance of several sodium transporters.22,61
Stroke volume is also reduced in response to stress in school-aged
children treated with dexamethasone neonatally for prematurity.50
Baroreceptor set point and sensitivity are known to change peri-
natally in foals and lambs to accommodate the rising postnatal
BP.32,37,62 There is a rightward shift in the baroreflex function curve
with increasing postal age in both species, which is accompanied by
alterations in the relative contribution of the vagal and sympathetic
components of HR regulation towards increased sympathetic
dominance, particularly in the foal.32,62 However, by adulthood,
parasympathetic activity appears to be the predominant factor
in the response to increasing BP in horses.63 Treatment of pregnant
ewes with synthetic glucocorticoids has been shown to cause a
rightward shift in the baroreflex function curve in the offspring
during fetal, neonatal, pre-weaning juvenile and adult
life.51,52,64–66 It also attenuated the gain of the baroreflex from as
early as 6 weeks of postnatal life.52,65,66 These alterations in
Table 2. Maximum (Max) increments and decrements inmean BP (mmHg) andHR (beats perminute, bpm) from basal values during the 10-min infusion of PE and SNP
in all ponies at 2–3 years of age and in the males and females separately after neonatal treatment with saline or ACTH. Doses of drugs are given in the text
Number of ponies
Saline ACTH
All Male Female All Male Female
8 4 4 9 4 5
PE infusion
Max increment in mean BP (mmHg) 76.4 ± 8.5 80.2 ± 8.4 72.8 ± 16.0 66.8 ± 5.1 72.2 ± 7.5 62.6 ± 7.0
Max decrement in HR (bpm) 18.3 ± 1.8 21.6 ± 2.7 14.9 ± 0.89 17.3 ± 1.9 15.9 ± 0.4 18.5 ± 3.4
SNP infusion
Max decrement in mean BP (mmHg) 28.2 ± 3.9 26.8 ± 4.4 29.7 ± 7.0 28.1 ± 2.4 24.5 ± 4.3 30.9 ± 2.3
Max increment in HR (bpm) 32.6 ± 4.2 27.2 ± 5.5 38.0 ± 5.7 31.8 ± 3.5 34.5 ± 6.6 29.7 ± 3.8
Gain of baroreflex curve* (bpm/mmHg) 1.07 ± 0.28 0.55 ± 0.18† 1.60 ± 0.57 0.69 ± 0.14 0.88 ± 0.28 0.54 ± 0.08†
*Significant interaction between sex and neonatal treatment (two-way ANOVA P < 0.01, significant effect of sex within saline-treated group and significant effect of treatment within females)
†Significantly less than the value in the saline-treated females (P < 0.01 two-way ANOVA with the Holm–Sidak post hoc test.
(c)(b)(a)
Fig. 3. Baroreflex function curves showing the relationship of mean arterial BP (mmHg) and HR (beats per minute) (mean ± SEM on x and y axes) in response to a hypertensive
challenge (PE infusion PE: 6 μg/kg/min) and a hypotensive challenge (SNP: 2.5 μg/kg/min) in ponies at 2–3 years of age after neonatal treatment with either saline (open symbols,
n = 8) and ACTH (filled symbols, n = 9) for (a) all animal irrespective of sex, (b) males only (saline, n = 4; ACTH, n = 4) and (c) females only (saline, n = 4; ACTH, n = 5).
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baroreflex sensitivity appeared to be due primarily to altered para-
sympathetic rather than sympathetic activity and were not associ-
ated with changes in the HR range, indicative of impaired central
processing of baroreceptor signals.46,60 In the current study, neo-
natal cortisol overexposure reduced the gain of the baroreflex curve
in the female, but not the male adult horses. This effect appeared to
be due predominantly to a decrease in the sympathetic component
of baroreflex control, which suggests that the normal ontogenic
increase in sympathetic dominance of the baroreflex seen after
birth may have been adversely affected by neonatal hypercortiso-
laemia.32 However, whether these developmental changes reflect
altered afferent signals, their central integration and/or responsive-
ness of the target organs to autonomic outflow remains unknown.
The efficacy of PE and SNP in inducing cardiovascular responses
reflects not only the receptor expression and downstream signalling
mechanisms but also the circulating concentration and clearance of
these receptor agonists. Prenatal glucocorticoid overexposure reduces
adult nephron numbers and increases glomerular filtration rate of
individual nephrons in female sheep,67 which may have implications
for SNP concentrations as renal excretion is the main route of SNP
clearance. However, relatively little is known about whether the renal
consequences of early life glucocorticoid overexposure are sex-linked
in adulthood.47 Similarly, PE clearance may be affected by neonatal
glucocorticoid overexposure as monoamine oxidase activity respon-
sible for PE clearance is sensitive to both early life programming and
the adult glucocorticoid concentration.68,69 Previous studies in the
current cohort of young adult horses have shown that the HPA
response to insulin-induced hypoglyacaemia is increased after neona-
tal cortisol overexposure.27,28 Although this heightened response was
not sex-linked,27,30 an elevated adult cortisol concentration, particu-
larly in response to SNP-induced hypotension, might also be a con-
tributory factor in the altered cardiovascular function seen in the
young adult ponies overexposed to cortisol neonatally. Consequently,
changes in PE and SNP clearance and, hence, concentrations may
also have a role in the altered cardiovascular responses seen between
sexes and after neonatal cortisol overexposure in the current
study.
The mechanisms underlying the sexual dimorphism of adult
cardiovascular function seen in young adult horses both under
basal conditions and in response to neonatal cortisol overexposure,
also remain unclear. Relatively few studies have examined the long-
term cardiovascular effects of early life overexposure to glucocor-
ticoids in both sexes in any species and those that have find either
little difference between the sexes or more adverse effects in males
than females in older animals.23,46,70,71 Cardiovascular function is
known to be affected by puberty and increased secretion of the dif-
ferent gonadal steroids.72–74 Consequently, the sexual dimorphism
in the cardiovascular outcomes of neonatal cortisol overexposure
in young 2- to 3-year-old ponies may, in part, reflect the earlier
onset of puberty in fillies, since full sexual maturity is reached
by 2 years in fillies but occurs up to a year later in colts.75
Differential effects of neonatal glucocorticoid treatment on
(a)
(b)
Fig. 4. The relative dominance of the (a) sympathetic and (b) parasympathetic components of the baroreflex curves measured as the relationship between the mean changes
(±SEM on x and y axes) in mean arterial BP (mmHg) and HR (beats per minute) in response to a hypotensive challenge (SNP: 2.5 μg/kg/min) and to a hypertensive challenge (PE
infusion: 6 μg/kg/min), respectively, in ponies at 2–3 years of age after neonatal treatment with either saline (open symbols, n= 8) and ACTH (filled symbols, n= 9) for (i) all animals
irrespective of sex, (ii) males only (saline, n= 4; ACTH, n= 4) and (iii) females only (saline, n= 4; ACTH, n= 5). *Significantly different from saline-treated group of females (two-way
ANOVA, P< 0.05 with Holm–Sidak post hoc test). †Significantly different from value in the saline-treated group of males in panel Aii (two-way ANOVA, P< 0.02 with the Holm–Sidak
post hoc test).
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cardiovascular function are also seen in peri-pubertal boys and
girls born pre-term.50 Collectively, these findings suggest that, in
long-lived species, sex-linked differences in cardiovascular func-
tion may be more obvious after puberty due to the cardio-protec-
tive effects of oestrogens.76,77 Certainly, the elevated basal diastolic
pressure and depressed gain of the cardiac baroreflex in control
colts relative to control fillies may reflect a greater propensity
for basal arterial BP to be easily stimulated in males relative to
females and is consistent with the greater susceptibility of men
than women to hypertension and cardiovascular dysfunction in
mid-life.78,79
In summary, the current study is the first to report the long-
term cardiovascular effects of neonatal glucocorticoid overexpo-
sure in horses. It shows that there is a window of susceptibility
for glucocorticoid programming of cardiovascular function in
the immediate neonatal period in horses that is sex-specific.
This is consistent with the endocrine and metabolic programming
observed in previous studies of these animals.28,29 The cardio-
vascular dysfunction measured in the young adult horses treated
with ACTH after birth occurred without alterations in basal BP,
which suggest that the abnormalities are not the consequence of
hypertension but are more likely to be a primary defect in develop-
ment of the heart and/or the blood vessels programmed by the
neonatal overexposure to cortisol. Further studies are needed to
determine whether these cardiovascular changes persist and
develop into overt hypertension and cardiovascular disease with
increasing age. However, the present findings per se have impor-
tant implications for the health and athletic performance of the
population of young adult horses involved in racing and other
sports, particularly if they have been clinically or naturally over-
exposed to glucocorticoids in the neonatal period.
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